An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions -: Relevance for Gaucher disease

被引:32
作者
Atrian, Silvia [1 ,2 ]
Lopez-Vinas, Eduardo [3 ]
Gomez-Puertas, Paulino [3 ]
Chabas, Amparo [4 ,5 ]
Vilageliu, Lluisa [1 ,2 ,5 ]
Grinberg, Daniel [1 ,2 ,5 ]
机构
[1] Univ Barcelona, Fac Biol, Dept Genet, E-08028 Barcelona, Spain
[2] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain
[3] CSIC, UAM, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
[4] Corporacio Sanitaria Clin, Hosp Clin, Inst Bioquim Clin, Barcelona, Spain
[5] Inst Salud Carlos III, CIBERER, Barcelona, Spain
关键词
correlated mutations; in silico modeling; structure-function relationship; GBA;
D O I
10.1002/prot.21554
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Gaucher disease, the most prevalent lysosomal storage disorder, is principally caused by malfunction of the lysosomal enzyme glucocerebrosidase (GBA), a 497-amino acid membrane glycoprotein that catalyzes the hydrolysis of glucosylceramide to ceramide and glucose in the presence of an essential 84-residue activator peptide named saposin C (SapC). Knowledge of the GBA structure, a typical (beta/alpha)(8) TIM barrel, explains the effect of few mutations, directly affecting or located near the catalytic site. To identify new regions crucial for proper GBA functionality, we analyzed the interactions of the enzyme with a second (substrate) and a third (cofactor) partner. We build 3D docking models of the GBA-SapC and the GBA-ceramide interactions, by means of methodologies that integrate both evolutive and structural information. The GBA-SapC docking model confirm the implication of three spatially closed regions of the GBA surface (TIM barrel-helix 6 and helix 7, and the Ig-like domain) in binding the SapC molecule. This model provides new basis to understand the pathogenicity of several mutations, such as the prevalent Leu444Pro, and the additive effect of Glu326Lys in the double mutant Glu326Lys-Leu444Pro. Overall, 39 positions in which amino acid changes are known to cause Gaucher disease were localized in the GBA regions identified in this work. Our model is discussed in relation to the phenotype (pathogenic effect) of these mutations, as well as to the enzymatic activity of the recombinant proteins when available. Both data fully correlates with the proposed model, which will provide a new tool to better understand Gaucher disease and to design new therapy strategies.
引用
收藏
页码:882 / 891
页数:10
相关论文
共 66 条
[1]
GAUCHERS-DISEASE VARIANT CHARACTERIZED BY PROGRESSIVE CALCIFICATION OF HEART-VALVES AND UNIQUE GENOTYPE [J].
ABRAHAMOV, A ;
ELSTEIN, D ;
GROSSTSUR, V ;
FARBER, B ;
GLASER, Y ;
HADASHALPERN, I ;
RONEN, S ;
TAFAKJDI, M ;
HOROWITZ, M ;
ZIMRAN, A .
LANCET, 1995, 346 (8981) :1000-1003
[2]
Expression and functional characterization of mutated glucocerebrosidase alleles causing Gaucher disease in Spanish patients [J].
Alfonso, P ;
Rodríguez-Rey, JC ;
Gañán, A ;
Pérez-Calvo, JI ;
Giralt, M ;
Giraldo, P ;
Pocoví, M .
BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) :218-225
[3]
Amaral O, 1996, HUM MUTAT, V8, P280, DOI 10.1002/(SICI)1098-1004(1996)8:3<280::AID-HUMU15>3.3.CO
[4]
2-6
[5]
Hematologically important mutations: Gaucher disease [J].
Beutler, E ;
Gelbart, T ;
Scott, CR .
BLOOD CELLS MOLECULES AND DISEASES, 2005, 35 (03) :355-364
[6]
GLUCOCEREBROSIDASE MUTATIONS IN GAUCHER DISEASE [J].
BEUTLER, E ;
DEMINA, A ;
GELBART, T .
MOLECULAR MEDICINE, 1994, 1 (01) :82-92
[7]
Beutler E, 1996, P ASSOC AM PHYSICIAN, V108, P179
[8]
BEUTLER E, 1994, HUM GENET, V93, P209
[9]
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[10]
Phage-display and correlated mutations identify an essential region of subdomain 1C involved in homodimerization of Escherichia coli FtsA [J].
Carettoni, D ;
Gómez-Puertas, P ;
Yim, L ;
Mingorance, J ;
Massidda, O ;
Vicente, M ;
Valencia, A ;
Domenici, E ;
Anderluzzi, D .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2003, 50 (02) :192-206